Christopher Reinhard
Fondatore presso GENE BIOTHERAPEUTICS, INC.
Profilo
Christopher J.
Reinhard is the founder of Collateral Therapeutics, Inc. (founded in 1996) and Taxus Cardium Pharmaceuticals Group, Inc. (founded in 2003).
He holds the title of Chief Executive Officer at Collateral Therapeutics, Inc. in 2002 and was previously the President, Chief Executive Officer & Director at Taxus Cardium Pharmaceuticals Group, Inc. since 2003.
Mr. Reinhard's current job is as the Chief Executive Officer at Tissue Repair Co. since 2006.
He has held various former positions including Chairman, President, CEO, CFO & Treasurer at Aries Ventures, Inc. from 2005 to 2006, Chief Executive Officer & Director at Post-Hypothermia Corp.
from 2006 to 2009, Chief Executive Officer & Director at To Go Brands, Inc. in 2012 to 2013, and Executive Chairman at Artes Medical, Inc. from 2004 to 2008.
He also served as a Director at Ontro, Inc., Managing Director & Vice President at The Henley Group, Inc. (New Hampshire), Vice President at IMED Corp, Vice President at Instrumentation Laboratory Co., and Vice President at Fisher Scientific Group, Inc. Mr. Reinhard obtained his undergraduate degree and MBA from Babson College.
Posizioni attive di Christopher Reinhard
| Società | Posizione | Inizio |
|---|---|---|
| GENE BIOTHERAPEUTICS, INC. | Fondatore | 22/12/2003 |
Tissue Repair Co.
 Tissue Repair Co. Medical SpecialtiesHealth Technology Tissue Repair Co. develops biopharmaceutical products for tissue regeneration. It is a biopharmaceutical company with a clinical-stage focus on products that promote tissue repair. Its scientific expertise is based on gene therapy, growth factor biology, tissue regeneration and product development. The company is headquartered in San Diego, CA | Amministratore Delegato | 01/01/2013 |
Precedenti posizioni note di Christopher Reinhard
| Società | Posizione | Fine |
|---|---|---|
To Go Brands, Inc.
 To Go Brands, Inc. Pharmaceuticals: MajorHealth Technology Part of Cell-nique Corp., To Go Brands, Inc. develops and markets health products. The company is based in San Diego, CA. To Go Brands was acquired by Cell-nique Corp. from Taxus Cardium Pharmaceuticals Group, Inc. on November 18, 2013 for $2.50 million. | Amministratore Delegato | 01/11/2013 |
Post-Hypothermia Corp.
 Post-Hypothermia Corp. Medical SpecialtiesHealth Technology Post-Hypothermia Corp. develops and provides temperature modulation therapy products for the healthcare industry. It also provides CoolBlue, a surface-based temperature modulation system that consists of a console and a disposable CoolBlue vest with upper thigh pads, which is designed for use in less acute patients or prolonged temperature management clinical settings. The company was founded by John D. Dobak in 1998 and is headquartered in San Diego, CA. | Amministratore Delegato | 01/07/2009 |
Artes Medical, Inc.
 Artes Medical, Inc. Financial ConglomeratesFinance Artes Medical, Inc. is a medical technology company. It is focused on developing, manufacturing and commercializing a new category of injectable aesthetic products for the dermatology and plastic surgery markets. Its products include ArteFill which is a non-resorbable aesthetic injectable implant for the correction of facial wrinkles known as smile lines, or nasolabial folds, for commercial sale in the U.S. The company was founded on August 24, 1999 and is headquartered in San Diego, CA. | Presidente | 01/01/2008 |
| Aries Ventures, Inc. | Amministratore Delegato | 23/01/2006 |
Collateral Therapeutics, Inc.
 Collateral Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Collateral Therapeutics, Inc. focuses on the discovery and development of non-surgical gene therapy product candidates for the potential treatment of cardiovascular diseases including: coronary artery disease; peripheral vascular disease; restenosis; congestive heart failure and heart attack. The company's core technology is centered on methods of cardiovascular gene therapy; a portfolio of therapeutic genes and gene delivery vectors. Its portfolio includes human genes in the Fibroblast Growth Factor (FGF) and Vascular Endothelial Growth Factor (VEGF) gene families to be used in investigational gene therapy product candidates. The company is headquartered in San Diego, CA. | Fondatore | 03/07/2002 |
Formazione di Christopher Reinhard
| Babson College | Masters Business Admin |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| GENE BIOTHERAPEUTICS, INC. | Health Technology |
| Aziende private | 11 |
|---|---|
| Aries Ventures, Inc. | Finance |
Ontro, Inc.
 Ontro, Inc. Miscellaneous ManufacturingProducer Manufacturing Ontro Inc. is engaged in the research and development of integrated thermal containers. Company has a proprietary technology which it has incorporated into a proposed product line of fully contained self-heating beverage containers designed to heat liquid contents such as coffee, tea, hot chocolate, soups, and alcoholic beverages. These containers are similar to typical beverage containers in size and shape and are activated by the consumer to heat the contents within a few minutes. The company seeks to develop and expand a consumer market for remote and mobile heating of beverages and other products. | Producer Manufacturing |
Collateral Therapeutics, Inc.
Collateral Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Collateral Therapeutics, Inc. focuses on the discovery and development of non-surgical gene therapy product candidates for the potential treatment of cardiovascular diseases including: coronary artery disease; peripheral vascular disease; restenosis; congestive heart failure and heart attack. The company's core technology is centered on methods of cardiovascular gene therapy; a portfolio of therapeutic genes and gene delivery vectors. Its portfolio includes human genes in the Fibroblast Growth Factor (FGF) and Vascular Endothelial Growth Factor (VEGF) gene families to be used in investigational gene therapy product candidates. The company is headquartered in San Diego, CA. | Commercial Services |
Tissue Repair Co.
Tissue Repair Co. Medical SpecialtiesHealth Technology Tissue Repair Co. develops biopharmaceutical products for tissue regeneration. It is a biopharmaceutical company with a clinical-stage focus on products that promote tissue repair. Its scientific expertise is based on gene therapy, growth factor biology, tissue regeneration and product development. The company is headquartered in San Diego, CA | Health Technology |
IMED Corp
 IMED Corp Medical SpecialtiesHealth Technology Part of Becton, Dickinson & Co., IMED Corp is a surgical and medical instruments company. The company is based in San Diego, CA. IMED was acquired by CareFusion 303, Inc. on October 18, 1993. | Health Technology |
Instrumentation Laboratory Co.
 Instrumentation Laboratory Co. Medical SpecialtiesHealth Technology Instrumentation Laboratory Co. manufactures diagnostic products. It offers critical care systems, hemostatis products and information management services. The firm provides services to the hospitals and clinical laboratories. Instrumentation Laboratory was founded in 1959 and is headquartered in Bedford, MA. | Health Technology |
Artes Medical, Inc.
Artes Medical, Inc. Financial ConglomeratesFinance Artes Medical, Inc. is a medical technology company. It is focused on developing, manufacturing and commercializing a new category of injectable aesthetic products for the dermatology and plastic surgery markets. Its products include ArteFill which is a non-resorbable aesthetic injectable implant for the correction of facial wrinkles known as smile lines, or nasolabial folds, for commercial sale in the U.S. The company was founded on August 24, 1999 and is headquartered in San Diego, CA. | Finance |
Post-Hypothermia Corp.
Post-Hypothermia Corp. Medical SpecialtiesHealth Technology Post-Hypothermia Corp. develops and provides temperature modulation therapy products for the healthcare industry. It also provides CoolBlue, a surface-based temperature modulation system that consists of a console and a disposable CoolBlue vest with upper thigh pads, which is designed for use in less acute patients or prolonged temperature management clinical settings. The company was founded by John D. Dobak in 1998 and is headquartered in San Diego, CA. | Health Technology |
| The Henley Group, Inc. (New Hampshire) | Health Technology |
To Go Brands, Inc.
To Go Brands, Inc. Pharmaceuticals: MajorHealth Technology Part of Cell-nique Corp., To Go Brands, Inc. develops and markets health products. The company is based in San Diego, CA. To Go Brands was acquired by Cell-nique Corp. from Taxus Cardium Pharmaceuticals Group, Inc. on November 18, 2013 for $2.50 million. | Health Technology |
| Fisher Scientific Group, Inc. |
- Borsa valori
- Insiders
- Christopher Reinhard
